Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects - Ronsein, Graziella E.; Hutchins, Patrick M.; Isquith, Daniel; Vaisar, Tomas; Zhao, Xue-Qiao; Heinecke, Jay W. (Arteriosclerosis, thrombosis, and vascular biology, 2016)
Keywords: Animals; Atorvastatin Calcium - therapeutic use; ATP Binding Cassette Transporter 1 - genetics; ATP Binding Cassette Transporter 1 - metabolism; Biological Transport; Carotid Artery Diseases - blood; Carotid Artery Diseases - diagnosis; Carotid Artery Diseases - drug therapy; Cell Line; Cholesterol - blood; Cholesterol, HDL - blood; Cricetinae; Drug Combinations; Dyslipidemias - blood; Dyslipidemias - diagnosis; Dyslipidemias - drug therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Macrophages - drug effects; Macrophages - metabolism; Male; Mice; Middle Aged; Niacin - therapeutic use; Time Factors; Transfection; Treatment Outcome; atherosclerosis; niacin; macrophages; cardiovascular diseases; triglycerides